Marshall Wace’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.7M Buy
376,617
+183,491
+95% +$13.2M 0.03% 567
2025
Q4
$12.3M Buy
193,126
+71,484
+59% +$4.41M 0.01% 799
2025
Q3
$7.67M Buy
+121,642
New +$8.49M 0.01% 1020
2025
Q2
Sell
-2,380
Closed -$210K 2826
2025
Q1
$210K Sell
2,380
-1,482
-38% -$140K ﹤0.01% 2389
2024
Q4
$353K Buy
+3,862
New +$396K ﹤0.01% 2185
2024
Q2
Sell
-11,578
Closed -$1.16M 2649
2024
Q1
$1.16M Buy
+11,578
New +$1.02M ﹤0.01% 1597
2022
Q4
Sell
-30,222
Closed -$2.15M 3053
2022
Q3
$2.15M Buy
+30,222
New +$2.72M ﹤0.01% 1962
2022
Q2
Sell
-21,412
Closed -$2.4M 3528
2022
Q1
$2.4M Buy
21,412
+21,391
+101,862% +$2.51M ﹤0.01% 1945
2021
Q4
$3K Buy
+21
New +$2.33K ﹤0.01% 3776
2021
Q3
Sell
-8,299
Closed -$969K 3119
2021
Q2
$969K Sell
8,299
-52,602
-86% -$6.32M ﹤0.01% 1824
2021
Q1
$6.71M Buy
+60,901
New +$6.61M 0.03% 669
2020
Q2
Sell
-79,225
Closed -$3.69M 1647
2020
Q1
$3.69M Sell
79,225
-170,866
-68% -$11M 0.04% 458
2019
Q4
$19.8M Buy
+250,091
New +$19.2M 0.14% 170
2019
Q2
Sell
-88,268
Closed -$6.7M 1470
2019
Q1
$6.7M Sell
88,268
-13,789
-14% -$1.1M 0.06% 378
2018
Q4
$7.46M Buy
+102,057
New +$8.14M 0.08% 329
2017
Q2
Sell
-40,301
Closed -$3.26M 336
2017
Q1
$3.26M Sell
40,301
-8,444
-17% -$664K 0.16% 107
2016
Q4
$3.67M Sell
48,745
-274,292
-85% -$19.8M 0.02% 539
2016
Q3
$21.9M Buy
323,037
+286,432
+782% +$19.2M 0.16% 160
2016
Q2
$2.48M Buy
+36,605
New +$2.69M 0.02% 537
2016
Q1
Sell
-50,052
Closed -$3.38M 1063
2015
Q4
$3.38M Buy
50,052
+7,098
+17% +$497K 0.03% 462
2015
Q3
$2.78M Sell
42,954
-231,601
-84% -$17.1M 0.03% 388
2015
Q2
$22.5M Sell
274,555
-43,853
-14% -$3.38M 0.29% 99
2015
Q1
$22.1M Buy
+318,408
New +$23M 0.29% 96
2014
Q3
Sell
-207,617
Closed -$18.1M 912
2014
Q2
$18.1M Buy
207,617
+198,121
+2,086% +$17.2M 0.27% 105
2014
Q1
$819K Buy
+9,496
New +$778K 0.01% 516

Other funds holding EMN

Marshall Wace's EMN Position: Q1 2026 in Review

Marshall Wace increased its Eastman Chemical (EMN) stake by 95% in Q1 2026, buying an estimated $13.2M and bringing the position to 376,617 shares worth $28.7M. The position accounts for 0.03% of the portfolio, ranked #567.

Marshall Wace first reported a position in EMN in Q1 2014 and has held it in 25 quarters since. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Marshall Wace held 376,617 shares of Eastman Chemical worth $28.7M as of Q1 2026.
  • Marshall Wace bought 183,491 Eastman Chemical shares in Q1 2026, an estimated $13.2M.
  • Eastman Chemical made up 0.03% of Marshall Wace's portfolio in Q1 2026, its #567 holding.
  • Marshall Wace first reported a position in Eastman Chemical in Q1 2014 and has held it in 25 quarters since.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.